Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin

Experimental Dermatology

Volumn 14, Issue 7, 2005, Pages 535-542

  Christensen, Rikke ^a   Alhonen, Leena ^b   Wahlfors, Jarmo ^b   Jakobsen, Maria ^a   Jensen, Thomas G ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

Metabolic diseases; Phenylketonuria; Skin; Transgenic models

Indexed keywords

CYTOKERATIN 1; CYTOKERATIN 14; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INVOLUCRIN; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; RNA;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS BREEDING; DISEASE MODEL; ENZYME ACTIVITY; EPIDERMIS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENOTYPE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHENYLKETONURIA; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; RNA EXTRACTION; SKIN; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GTP CYCLOHYDROLASE; HUMANS; KERATIN-14; KERATINS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, TRANSGENIC; PHENOTYPE; PHENYLALANINE; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; SKIN;

EID: 21244503093     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00326.x     Document Type: Article

References (24)

1. Christensen R, Kolvraa S, Blaese R M, Jensen T G. Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes. Gene Ther 2000: 7: 1971-1978.
2. Mochizuki S, Mizukami H, Ogura T et al. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice. Gene Ther 2004: 11: 1081-1086.
3. Fang B, Eisensmith R C, Li X H et al. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther 1994: 1: 247-254.
4. Nagasaki Y, Matsubara Y, Takano H et al. Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer. Pediatr Res 1999: 45: 465-473.
5. Harding C O, Wild K, Chang D, Messing A, Wolff J A. Metabolic engineering as therapy for inborn errors of metabolism - development of mice with phenylalanine hydroxylase expression in muscle. Gene Ther 1998: 5: 677-683.
6. Harding C O, Neff M, Jones K, Wild K, Wolff J A. Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pahenu2 mice. J Gene Med 2003: 5: 984-993.
7. Lin C M, Tan Y, Lee Y M, Chang C C, Hsiao K J. Expression of human phenylalanine hydroxylase activity in T lymphocytes of classical phenylketonuria children by retroviral-mediated gene transfer. J Inherit Metab Dis 1997: 20: 742-754.
8. Rosenthal D S, Steinert P M, Chung S et al. A human epidermal differentiation-specific keratin gene is regulated by calcium but not negative modulators of differentiation in transgenic mouse keratinocytes. Cell Growth Differ 1991: 2: 107-113.
9. Rothnagel J A, Greenhalgh D A, Longley M A, Bundman D, Dominey A M, Roop D R. Development of an epidermal-specific expression vector for targeting gene expression to the epidermis of transgenic mice. J Invest Dermatol 1990: 94: 573.
10. Wang X, Zinkel S, Polonsky K, Fuchs E. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. Proc Natl Acad Sci USA 1997: 94: 219-226.
11. Larcher F, Del Rio M, Serrano F et al. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. Faseb J 2001: 15: 1529-1538.
12. Fakharzadeh S S, Zhang Y, Sarkar R, Kazazian H H Jr. Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 2000: 95: 2799-2805.
13. Ellis T, Smyth I, Riley E et al. Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis. Dev Biol 2003: 263: 203-215.
14. Matsumoto T, Jiang J, Kiguchi K et al. Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol Carcinog 2002: 33: 146-155.
15. Johnson L D, Idler W W, Zhou X M, Roop D R, Steinert P M. Structure of a gene for the human epidermal 67-kDa keratin. Proc Natl Acad Sci USA 1985: 82: 1896-1900.
16. Hogan B, Constantine F, Lacy E. Manipulating the Mouse Embryo. New York, NY: Cold Spring Harbor Laboratory, 1986: 1-332.
17. Triel C, Vestergaard M E, Bolund L, Jensen T G, Jensen U B. Side population cells in the human and mouse epidermis lack stem cell characteristics. Exp Cell Res 2004: 295: 79-90.
18. Christensen R, Guttler F, Jensen T G. Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria. Mol Genet Metab 2002: 76: 313-318.
19. McCaman M, Robins E. Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 1962: 59: 885-890.
20. Greenberg N M, Anderson J W, Hsueh A J et al. Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice. Proc Natl Acad Sci USA 1991: 88: 8327-8331.
21. Overbeek P A, Aguilar-Cordova E, Hanten G et al. Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1991: 1: 31-37.
22. Jankowsky J L, Slunt H H, Ratovitski T, Jenkins N A, Copeland N G, Borchelt D R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001: 17: 157-165.
23. Greenhalgh D A, Rothnagel J A, Quintanilla M I et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol Carcinog 1993: 7: 99-110.
24. Carroll J M, Albers K M, Garlick J A, Harrington R, Taichman L B. Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 1993: 90: 10270-10274.